Watchlist Price Alert

Citius Oncology Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.87

0.03 (2.96%)

At close: May 09, 2025, 3:58 PM

0.90

3.25%

After-hours: May 09, 2025, 04:50 PM EDT

Citius Oncology Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Apr 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-6.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.39K	-9.39K
Net Income	-6.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.39K	-9.39K
Selling & General & Admin	5.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research & Development	1.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	6.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Income Tax Expense	280.66K	21.15K	19.52K	17.48K	15.57K	12.7K	16.08K	15.65K	12.72K	10.87K	2.3K	n/a
Shares Outstanding (Basic)	71.55M	71.55M	66.53M	66.53M	89.41M	89.42M	90.16M	90.16M	90.16M	90.16M	81.4M	66.42M
Shares Outstanding (Diluted)	71.55M	71.55M	66.53M	66.53M	89.41M	89.42M	90.16M	90.16M	90.16M	90.16M	81.4M	66.42M
EPS (Basic)	-0.09	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00
EPS (Diluted)	-0.09	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	-0.00
EBITDA	-6.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.39K	-9.39K
EBIT	-6.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.39K	-9.39K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a